drugset / Trial / NCT02992808

Androgenic Profile Following Controlled Ovarian Stimulation

NCT02992808

Phase 4 Unknown 100 enrolled Sheba Medical Center
Non-randomizedParallel-groupOpen-labelTreatment

Summary

In this study the investigators will try to discover whether there is a difference for any of the stimulation preparations - recombinant FSH + recombinant LH (pergoveris \& luveris) vs. human menopausal gonadotropin (menopur) during GnRH-antagonist cycles in the meaning of androgenic hormones profile. The study question is whether using recombinant LH will result in different follicular hormonal milieu, serum endocrine profile or IVF outcomes than using highly purified urinary gonadotropins with hCG mimicking LH activity.

Timeline

Start
2016-12
Primary completion
2018-01
Completion
2020-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Luveris Protein / enzyme biologic
Comparator Menopur Protein / enzyme biologic
Comparator Pergoveris Protein / enzyme biologic 75 iu
Comparator Pergoveris Protein / enzyme biologic 150 iu

Indications